Titles
- Testing of glycerin, propylene glycol, maltitol solution, hydrogenated starch hydrolysate, sorbitol solution, and other high-risk drug components for diethylene glycol and ethylene glycol: guidance for industry1
- Testing of retroviral vector-based human gene therapy products for replication competent retrovirus during product manufacture and patient follow-up1
- Texas Health Harris Methodist-Cleburne: a system approach to surgical improvement1
- Texas: Latino children's health coverage facts1
- Tezepelumab for severe asthma: final report2
- That pesky human factor1
- The "One Care" Program at Commonwealth Care Alliance: partnering with Medicare and Medicaid to improve care for nonelderly dual eligibles1
- The "deemed to be a license" provision of the BPCI Act: questions and answers1
- The 160-pound computer that can be mass-produced by unskilled labor1
- The 2008 presidential candidates' health reform proposals: choices for America1
- The 2018 long-term budget outlook1
- The 2019 long-term budget outlook1
- The 2021 CHCF California Health Policy Survey1
- The AARP ads and the new Medicare prescription drug law1
- The ABCs of APCDs: how states are using claims data to understand and improve care1
- The ACA and Medicaid expansion waivers1
- The ACA and people with HIV: profiles from the field1
- The ACA's basic health program option: federal requirements and state trade-offs1
- The AcademyHealth Listening Project: improving the evidence base for Medicaid policymaking1
- The AcademyHealth Listening Project: improving the evidence base for Medicare policymaking1